Policy Notices

• Reminder to AHRQ Grantees that FY2017 Funds will Expire on September 30, 2022
  (NOT-HS-22-009)
  Agency for Healthcare Research and Quality
  

General Notices

• NCCIH Announces Availability of Frequently Asked Questions (FAQs) for RFA-AT-22-001 NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional)
  (NOT-AT-22-001)
  National Center for Complementary and Integrative Health
  National Institute on Aging
  

• Notice of Availability of Pre-Application Webinar Recording and FAQs for the HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (RFA-CA-21-045, RFA-CA-21-046, and RFA-CA-21-047) Funding Opportunity Announcements
  (NOT-CA-22-018)
  National Cancer Institute
  

• The National Institutes of Health (NIH) UNITE Announces Listening Sessions Inviting NIH Stakeholders to Discuss Racial & Ethnic Equity
  (NOT-OD-22-027)
  Office of the Director, NIH
  

• Request for Information (RFI): Highest Priority Needs for Ferret and Hamster Immunoreagents
  (NOT-AI-22-011)
  National Institute of Allergy and Infectious Diseases
  

Notice of Changes to Funding Opportunities

• Notice of NCIPC Participation in PA-21-071 "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"
  (NOT-CE-22-001)
  Centers for Disease Control and Prevention
  

• Notice to Rescind NOT-EY-21-001, "Notice of Special Interest (NOSI): National Research Service Award (NRSA) F32 Postdoctoral Fellowship Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities"
  (NOT-EY-22-001)
  National Eye Institute
  

• Notice to update the Application Due Dates for PAR-18-604 "Vet-LIRN Network Capacity-Building Projects"
  (NOT-FD-22-001)
  Food and Drug Administration
  

• Notice of Correction to NHLBI-Specific language in RFA-AT-22-004, "HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)"
  (NOT-HL-22-005)
  National Heart, Lung, and Blood Institute
  

• Notice of Change to Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01)
  (NOT-HS-22-006)
  Agency for Healthcare Research and Quality
  

• Notice of Change to Funding Opportunity Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18)
  (NOT-HS-22-008)
  Agency for Healthcare Research and Quality
  

• Notice of NINR Participation in PAR-21-080, Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)
  (NOT-NR-22-005)
  National Institute of Nursing Research
  

• Notice of NINR Participation in PAR-21-081, Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional)
  (NOT-NR-22-006)
  National Institute of Nursing Research
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) FOA
  (NOT-DE-21-020)
  National Institute of Dental and Craniofacial Research
  

• Notice of Intent to Publish the "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15, Clinical Trial Required)" FOA
  (NOT-HD-21-047)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Allergy and Infectious Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
  (NOT-MH-22-055)
  National Institute of Mental Health
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings
  (NOT-DA-21-060)
  National Institute on Drug Abuse
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI): Mechanistic studies on the impact of substance use in sex and gender differences in HIV-associated neurocognitive disorders
  (NOT-DA-22-047)
  National Institute on Drug Abuse
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): The Functional Oral Microbiome
  (NOT-DE-21-015)
  National Institute of Dental and Craniofacial Research
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Availability of Administrative Supplements to NIGMS Funded Awards for Building Cloud-Based Learning Modules
  (NOT-GM-22-004)
  National Institute of General Medical Sciences
  

• Notice of Special Interest (NOSI): Administrative Supplements for Embedded Ethicists into BRAIN Initiative Supported Research
  (NOT-MH-22-040)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest (NOSI): Secondary Analysis of Posttraumatic Psychopathology Data
  (NOT-MH-22-045)
  National Institute of Mental Health
  

Funding Opportunities

• Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)
  (PAR-21-342)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
  (PAR-21-343)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
  (PAR-22-047)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
  (PAR-22-055)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): March 22, 2023
  
  

• Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)
  (PAR-22-064)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Eye Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  Office of Research on Women's Health
  Application Receipt Date(s): January 07, 2025
  
  

• Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed)
  (PAR-22-066)
  National Institute of Mental Health
  Application Receipt Date(s): January 07, 2025
  
  

• Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed)
  (PAR-22-067)
  National Institute of Mental Health
  Application Receipt Date(s): January 07, 2025
  
  

• NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
  (PAR-22-070)
  National Eye Institute
  Application Receipt Date(s): January 07, 2025
  
  

• Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
  (PAR-22-073)
  National Cancer Institute
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Institute for Occupational Safety and Health
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): December 15, 2021; February 2, 2022; November 15, 2022; February 2, 2023; November 15, 2023; February 2, 2024 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Understanding Place-Based Health Inequalities in Mid-Life (R01 Clinical Trial Not Allowed)
  (RFA-AG-23-004)
  National Institute on Aging
  Application Receipt Date(s): March 03, 2022
  
  

• HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)
  (RFA-AT-22-003)
  National Center for Complementary and Integrative Health
  National Center for Advancing Translational Sciences
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  Application Receipt Date(s): February 11, 2022
  
  

• NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional)
  (RFA-DA-22-036)
  National Institute on Drug Abuse
  National Institute on Aging
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): March 02, 2022
  
  

• Age-related Macular Degeneration (AMD) Integrative Biology Initiative: Discovery of AMD Pathobiology using Patient-Derived Induced Pluripotent Stem Cell (iPSC)-derived Retinal Pigment Epithelium (RPE) (U01 Clinical Trial Not Allowed)
  (RFA-EY-21-002)
  National Eye Institute
  Application Receipt Date(s): February 17, 2022
  
  

• NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
  (RFA-HL-23-008)
  National Heart, Lung, and Blood Institute
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): February 28, 2024
  
  

• NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
  (RFA-HL-23-009)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): February 28, 2024
  
  

• Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required)
  (RFA-MH-22-150)
  National Institute of Mental Health
  Application Receipt Date(s): January 12, 2023
  
  

• Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed)
  (RFA-NS-22-013)
  National Institute of Neurological Disorders and Stroke
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Not Applicable
  
  

• Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Clinical Coordinating Center (CCC) (U24 Clinical Trial Not Allowed)
  (RFA-NS-22-014)
  National Institute of Neurological Disorders and Stroke
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Not Applicable
  
  

• Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Network Clinical Center (Hub) (U24 Clinical Trial Not Allowed)
  (RFA-NS-22-015)
  National Institute of Neurological Disorders and Stroke
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): January 18, 2022
  
  

• NIOSH Education and Research Centers
  (RFA-OH-22-001)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): November 21, 2025
  
  

• Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)
  (RFA-RM-22-006)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): June 10, 2022